Ulinastatin Reduces Cancer Recurrence after Resection of Hepatic Metastases from Colon Cancer by Inhibiting MMP-9 Activation via the Antifibrinolytic Pathway
Figure 9
Immunohistochemistry of MMP-9 and Ki-67 in liver tissues. (a) Immunohistochemistry staining of MMP-9 in liver tissues from negative controls; (b) immunohistochemistry staining of MMP-9 in liver tissues from the advanced-stage treatment groups; (c) immunohistochemistry staining of MMP-9 in liver tissues from the early-stage treatment groups; (d) immunohistochemistry staining of Ki-67 in liver tissues from negative controls; (e) immunohistochemistry staining of Ki-67 in liver tissues from the advanced-stage treatment groups; (f) immunohistochemistry staining of Ki-67 in liver tissues from the early-stage treatment groups.
